Atypical Hemolytic Uremic Syndrome
2 competing products in clinical development for Atypical Hemolytic Uremic Syndrome.
Pipeline by Phase
Phase 32
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Crovalimab | Chugai Pharmaceutical | Phase 3 | Active | 44 |
| Crovalimab | Chugai Pharmaceutical | Phase 3 | Active | 44 |